Page 85 - Cardiac Nursing
P. 85

0
                             0
                             0
                           xd
                          q
                                                p
                           xd
                              6/3
                                  009
                                  009
                                     1
                                                p
                              6/3
                                0/2
                                0/2
                                                  r
                   p
                    04
                                                  r
                   p
                                                 ta
                                                 ta
                    04
                        68.
                          q
                          q
                        68.
                      2-0
                      2-0
                                                p
                                     1
         LWB
         LWB
         LWBK340-c02_ pp042-068.qxd  06/30/2009  15:33  Page 61 Aptara a a
                                              1 A
                                              1 A
            K34
                 02_
               0-c
               0-c
            K34
                 02_
                                            e 6
                                        3
                                         Pa
                                        3
                                      5:3
                                      5:3
                                         Pa
                                           g
                                           g
                                           g
                                         Pa
                                            e 6
                                                   C HAPTER 2 / Systemic and Pulmonary Circulation and Oxygen Delivery  61
                   vasodilation, any of these conditions in the pulmonary circula-  Causes of Arterial Hypoxemia
                   tion may cause arteriolar vasoconstriction. In well-ventilated re-  There are six sources of arterial hypoxemia:
                   gions, there is little vasoconstriction in response to deoxygenated
                                                                       ■ Decreased partial pressure of inspired oxygen
                   blood. In poorly ventilated areas where the amount of alveolar
                                                                       ■ Decreased percentage of inspired oxygen (decreased fraction of
                   oxygen is less than normal, such as when a bronchus is ob-
                   structed, vasoconstriction occurs and blood is shunted to other  inspired oxygen, FI O )
                                                                                        2
                                                                       ■ Diffusion limitation
                   lung areas.
                                                                       ■ Hypoventilation
                     Distribution of pulmonary blood flow in normal adults is
                                                                         ˙ ˙
                                                                       ■ V/Q mismatch
                   normally controlled to a greater extent by the hydrostatic pressure
                                                                       ■ Shunt
                   gradient discussed earlier. Active control of pulmonary circula-
                   tion, for example hypoxic vasoconstriction, serves a useful role in  Decreases in the atmospheric pressure related to higher alti-
                   diverting blood flow to areas of the lung with more abundant oxy-  tude result in a proportional decrease in the partial pressure of
                   gen, thus improving gas exchange. In contrast to peripheral vas-  inspired oxygen (PI O ). These conditions are common to high-
                                                                                      2
                   culature, which vasodilates in response to hypoxia, pulmonary  altitude locations and air travel; however, they are rarely encoun-
                   vessels constrict (e.g., HPV) to shunt blood away from poorly  tered in the clinical setting. Decreased percentage of inspired oxygen
                   ventilated areas to match perfusion and ventilation. 167  HPV oc-  (FI O ) occurs in situations in which other gases may displace oxy-
                                                                          2
                   curs within seconds in response to alveolar hypoxia and decreased  gen and lower the overall percentage of oxygen below 21% (e.g.,
                   mixed venous (pulmonary arterial) PO 2 , with alveolar PO 2 exert-  diagnostic testing, fire). Diffusion limitation can potentially cause
                   ing a greater effect. 156  The exact mechanism of HPV is unknown;  abnormal diffusion of oxygen across the alveolar–capillary mem-
                   however, the most  likely cause is  hypoxia-induced vascular  brane. Diffusion limitation can be caused by increases in the
                   smooth muscle hyperpolarization, which leads to increased intra-  thickness of the diffusion pathway and/or decreased transit time
                   cellular calcium and subsequent vasoconstriction.  168–170  Other  through the pulmonary circulation. Hypoventilation can result in
                   factors that are endothelium dependent, and may modulate hy-  a decrease in alveolar PO 2 caused by insufficient gas exchange be-
                   poxic vasoconstriction and cause vascular remodeling, include  tween the external environment and the alveoli. Hypoventilation
                   inhibition of NO production, decreased effect of prostacyclin and  can result from trauma to the chest wall, paralysis of the respira-
                   increased endothelin. 156,171  Of clinical importance, while inhaled  tory muscles, and medications such as morphine sulfate and bar-
                   NO has been used to acutely treat pulmonary hypertension, its ef-  biturates, which depress the respiratory center. 179
                   fectiveness is equivocal, 172  and a recent meta-analysis recom-  Matching ventilation of the alveoli with perfusion of the pul-
                                                                                                      ˙ ˙
                   mended that NO not be used for the treatment of acute respira-  monary capillary bed is a delicate balance. V/Q matching is a dy-
                   tory  distress syndrome. 173  In contrast, phosphodiesterase  namic process with different distributions occurring simultane-
                   inhibitors, which enhance NO-mediated vasodilation have been  ously within the regions of the lungs. In disease, there are a myriad
                                                                         ˙ ˙
                   found to improve outcomes. 174,175  In addition, endothelin recep-  of V/Q relationships exemplified by regions receiving excessive
                   tor antagonists have become first-line therapy for pulmonary ar-  ventilation (dead space), normal ventilation and perfusion (ideal),
                   terial hypertension 176  and intravenous prostacylin is reserved for  and excessive perfusion (shunt).
                   severely ill patients. 175,177                        Shunt refers to the condition when blood passes into the sys-
                     When blood flow to a region of the lung is decreased, there is  temic circulation without passing through a ventilated region of
                   also a decrease in alveolar CO 2 . The bronchial smooth muscle re-  the lung. Under normal conditions, there exists a small physio-
                   sponds to the decreased alveolar CO 2 levels by constricting; thus,  logical shunt because of the difference in PO 2  between alveolar gas
                   shifting ventilation away from a poorly perfused area. This re-  and end-capillary blood. Physiologically, mixed venous blood
                   sponse occurs in conditions such as prolonged high altitude or in  from the pulmonary arterial bed mixes with capillary blood from
                   patients with chronic obstructive pulmonary disease or prolonged  pulmonary venous beds, thereby lowering the end-capillary PO 2 .
                   pulmonary hypertension. 178                         This difference can become larger in conditions such as ventricu-
                     Ventilation and perfusion must occur in equal proportion in  lar septal defect, in which greater amounts of venous blood are
                   the various regions of the lung to achieve adequate gas exchange.  added to arterial blood across the defect, resulting in a lower Pa O .
                                                                                                                     2
                   Gas exchange determines the levels of alveolar oxygen partial pres-  An important clinical characteristic of a shunt is that the hy-
                   sure (PA O ) and carbon dioxide partial pressure (PA CO ). An ade-  poxemia cannot be completely resolved by placing the patient on
                          2                                2
                   quate alveolar PO 2 depends on a balance of two factors: the rate of  an inspired oxygen fraction (FI O ) of 100%. Because the shunt
                                                                                               2
                   removal of oxygen by the pulmonary arterial blood and the rate of  blood bypasses the ventilated regions of the lung, it is not exposed
                   replenishment of oxygen by alveolar ventilation. An adequate  to the higher alveolar PO 2 . In patients with shunt, the arterial
                   PA CO depends on the rate of removal of carbon dioxide by alve-  PCO 2  may be low, normal, or high, depending on the capacity to
                       2
                   olar ventilation. A key concept used to understand pulmonary gas  increase respiratory drive in response to hypoxemia.
                                                    ˙ ˙
                   exchange is the ventilation–perfusion ratio (V/Q).The concen-
                   tration of gases (i.e., oxygen, carbon dioxide, nitrogen) in the   Gas Transport
                   various regions of the lung is determined by the ratio of the rate
                   of ventilation to the rate of perfusion (blood flow). Obstruction  Gas Exchange
                   to ventilation or perfusion leads to alteration in this ratio and, con-  In the lungs, oxygen and carbon dioxide equilibrate across the
                   sequently, the composition of gases. Inequality in ventilation–  alveolar–capillary membranes by simple passive diffusion, mov-
                   perfusion  hinders the  lungs’ ability to replenish oxygen and   ing from an area of greater partial pressure to a region of lesser
                   remove carbon dioxide. Impairment of gas exchange can result in  partial pressure. The partial pressure of oxygen in pulmonary
                                 and an increase in tissue PCO 2 . Clinically, these  arterial blood (venous blood from the body) is approximately
                   a decrease in Pa O 2
                   conditions can result in hypoxemia.                 40 mm Hg, whereas pulmonary alveolar partial pressure of
   80   81   82   83   84   85   86   87   88   89   90